[2017 ESC/EACTS Guidelines for the management of valvular heart disease].

Authors/Task Force Members: Helmut Baumgartner* (ESC Chairperson) (Germany), Volkmar Falk* (EACTS Chairperson) (Germany), Jeroen J. Bax (The Netherlands), Michele De Bonis (Italy), Christian Hamm (Germany), Per Johan Holm (Sweden), Bernard Iung (France), Patrizio Lancellotti (Belgium), Emmanuel Lansac (France), Daniel Rodriguez Mu~ noz (Spain), Raphael Rosenhek (Austria), Johan Sjögren (Sweden), Pilar Tornos Mas (Spain), Alec Vahanian (France), Thomas Walther (Germany), Olaf Wendler (UK), Stephan Windecker (Switzerland), Jose Luis Zamorano (Spain)

[1]  J. Bonnet,et al.  Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study. , 2000, Journal of the American College of Cardiology.

[2]  J. Labèque,et al.  Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients. , 2004, Journal of the American College of Cardiology.

[3]  B. Iung,et al.  Relationship Between Valve Calcification and Long-Term Results of Percutaneous Mitral Commissurotomy for Rheumatic Mitral Stenosis , 2014, Circulation. Cardiovascular interventions.

[4]  L. W. Andersen,et al.  Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. , 2015, Journal of the American College of Cardiology.

[5]  Ischemic Mitral Regurgitation Long-Term Outcome and Prognostic Implications With Quantitative Doppler Assessment , 2001 .

[6]  E. Lansac,et al.  A lesional classification to standardize surgical management of aortic insufficiency towards valve repair. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[8]  Alec Vahanian,et al.  Epidemiology of acquired valvular heart disease. , 2014, The Canadian journal of cardiology.

[9]  E. Lansac,et al.  Reported Outcome After Valve-Sparing Aortic Root Replacement for Aortic Root Aneurysm: A Systematic Review and Meta-Analysis. , 2015, The Annals of thoracic surgery.

[10]  C. Eaton,et al.  Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council , 2009, Circulation.

[11]  B. Iung,et al.  Late Results of Percutaneous Mitral Commissurotomy up to 20 Years: Development and Validation of a Risk Score Predicting Late Functional Results From a Series of 912 Patients , 2012, Circulation.

[12]  E. Foster,et al.  4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. , 2013, Journal of the American College of Cardiology.

[13]  Timothy J Gardner,et al.  Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. , 2014, The New England journal of medicine.

[14]  J. Hausleiter,et al.  Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. , 2013, Journal of the American College of Cardiology.

[15]  J. Chambers,et al.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.

[16]  A. Evangelista,et al.  Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial. , 2016, European heart journal.

[17]  K. Phan,et al.  Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  P. Pibarot,et al.  Low-gradient aortic stenosis. , 2016, European heart journal.

[19]  F. Mohr,et al.  EACTS clinical statement: guidance for the provision of adult cardiac surgery. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  Yong-Jin Kim,et al.  Quantification of Right Ventricular Volume and Function Using Single-Beat Three-Dimensional Echocardiography: A Validation Study with Cardiac Magnetic Resonance. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[21]  J. Carapetis,et al.  Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease , 2013, Nature Reviews Cardiology.

[22]  R. Suri.  Outcome After Aortic Valve Replacement for Low-Flow/Low-Gradient Aortic Stenosis Without Contractile Reserve on Dobutamine Stress Echocardiography , 2010 .

[23]  B. Iung,et al.  TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. , 2016, European heart journal.

[24]  A. Delago,et al.  Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry. , 2016, JACC. Cardiovascular interventions.

[25]  C. Tribouilloy,et al.  Low‐Gradient Aortic Stenosis Operative Risk Stratification and Predictors for Long‐Term Outcome: A Multicenter Study Using Dobutamine Stress Hemodynamics , 2003, Circulation.

[26]  R. de Caterina,et al.  Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial , 2015, Circulation.

[27]  N. Geller,et al.  Surgical ablation of atrial fibrillation during mitral-valve surgery. , 2015, The New England journal of medicine.

[28]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[29]  Rossella Fattori,et al.  Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging: endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[30]  Tom Adriaenssens,et al.  Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial , 2013, The Lancet.

[31]  M. Mack,et al.  Mitral Annulus Calcification. , 2015, Journal of the American College of Cardiology.

[32]  M. Enriquez-Sarano,et al.  Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. , 2009, Journal of the American College of Cardiology.

[33]  J. Hung,et al.  Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis. , 2013, European heart journal.

[34]  Benjamin R. Szwejkowski,et al.  The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study. , 2011, Journal of the American College of Cardiology.

[35]  C. Indolfi,et al.  LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial. , 2010, American heart journal.

[36]  Juan Carlos Souto,et al.  Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data , 2012, The Lancet.

[37]  J. Leipsic,et al.  Transcatheter Aortic and Mitral Valve-in-Valve Implantation for Failed Surgical Bioprosthetic Valves: An 8-Year Single-Center Experience. , 2015, JACC. Cardiovascular interventions.

[38]  F. Tubach,et al.  Marfan Sartan: a randomized, double-blind, placebo-controlled trial. , 2015, European heart journal.

[39]  L. Cohn,et al.  Long-term outcomes of tricuspid valve replacement in the current era. , 2005, The Annals of thoracic surgery.

[40]  P. Oberti,et al.  Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation. , 2009, Journal of the American College of Cardiology.

[41]  I. Palacios,et al.  Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. , 1988, British heart journal.

[42]  Sean M. O'Brien,et al.  Predictors of mitral valve repair: clinical and surgeon factors. , 2010, The Annals of thoracic surgery.

[43]  Jeroen J. Bax,et al.  Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint. , 2017, European heart journal.

[44]  A. Evangelista,et al.  Prognostic value of preoperative indexed end-systolic left ventricle diameter in the outcome after surgery in patients with chronic aortic regurgitation. , 2008, American heart journal.

[45]  G. Lip,et al.  Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. , 2016, The New England journal of medicine.

[46]  L. De Luca,et al.  Twenty year follow-up after successful percutaneous balloon mitral valvuloplasty in a large contemporary series of patients with mitral stenosis. , 2014, International journal of cardiology.

[47]  G. Lip,et al.  Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis , 2016, European heart journal.

[48]  J. Coselli,et al.  3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. , 2016, Journal of the American College of Cardiology.

[49]  C. Mok,et al.  Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. , 1985, Circulation.

[50]  Chad Hughes,et al.  Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. , 2014, The Journal of thoracic and cardiovascular surgery.

[51]  P. Pellikka,et al.  Global Strain in Severe Aortic Valve Stenosis: Relation to Clinical Outcome After Aortic Valve Replacement , 2012, Circulation. Cardiovascular imaging.

[52]  L. Pierard,et al.  Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. , 2005, European heart journal.

[53]  Joseph P Desimone,et al.  Effect of preoperative pulmonary hypertension on outcomes in patients with severe aortic stenosis following surgical aortic valve replacement. , 2013, The American journal of cardiology.

[54]  J. Chambers,et al.  Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction , 2011, Circulation.

[55]  Jeroen J. Bax,et al.  Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Societ , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[56]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[57]  A. Andalib,et al.  TRANSCATHETER HEART VALVE FAILURE: A SYSTEMATIC REVIEW , 2014 .

[58]  J. Gummert,et al.  Telemedicine-guided, very low-dose international normalized ratio self-control in patients with mechanical heart valve implants. , 2015, European heart journal.

[59]  P. Pibarot,et al.  The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. , 2013, Journal of the American College of Cardiology.

[60]  Saeed Elassy,et al.  Urgent cardiac surgery during pregnancy: a continuous challenge. , 2014, The Annals of thoracic surgery.

[61]  H. Schunkert,et al.  Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial. , 2015, Journal of the American College of Cardiology.

[62]  E. Peterson,et al.  Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. , 2004, Journal of the American College of Cardiology.

[63]  V. Aboyans,et al.  [2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]. , 2014, Kardiologia polska.

[64]  R. Torguson,et al.  Society of Thoracic Surgeons Score Variance Results in Risk Reclassification of Patients Undergoing Transcatheter Aortic Valve Replacement , 2017, JAMA cardiology.

[65]  S. Yusuf,et al.  Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy). , 2016, Circulation.

[66]  H. Kılıç,et al.  Tricuspid balloon valvuloplasty to treat tricuspid stenosis. , 2010, The Journal of heart valve disease.

[67]  S. Bolling,et al.  Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. , 2005, Journal of the American College of Cardiology.

[68]  Ashish S Shah,et al.  Operative outcomes in mitral valve surgery: combined effect of surgeon and hospital volume in a population-based analysis. , 2013, The Journal of thoracic and cardiovascular surgery.

[69]  G. Porenta,et al.  Predictors of outcome in severe, asymptomatic aortic stenosis , 2001 .

[70]  A. Jaffe,et al.  B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. , 2014, Journal of the American College of Cardiology.

[71]  L. Tarantini,et al.  Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis , 2010, Heart.

[72]  Sebastian Schneeweiss,et al.  A combined comorbidity score predicted mortality in elderly patients better than existing scores. , 2011, Journal of clinical epidemiology.

[73]  M. Mack,et al.  Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement: Results From the PARTNER (Placement of Aortic Transcatheter Valve) Trial , 2014, Circulation.

[74]  J. Leipsic,et al.  Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis , 2016, The Lancet.

[75]  I. Palacios,et al.  The Echo Score Revisited: Impact of Incorporating Commissural Morphology and Leaflet Displacement to the Prediction of Outcome for Patients Undergoing Percutaneous Mitral Valvuloplasty , 2014, Circulation.

[76]  D. Dvir,et al.  Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients. , 2014, European heart journal.

[77]  S. Colan,et al.  Atenolol versus losartan in children and young adults with Marfan's syndrome. , 2014, The New England journal of medicine.

[78]  L. Køber,et al.  Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant: A Nationwide Cohort Study , 2014, Circulation.

[79]  Sean M. O'Brien,et al.  Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007. , 2012, The Annals of thoracic surgery.

[80]  Sean M. O'Brien,et al.  Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. , 2012, Journal of the American College of Cardiology.

[81]  A. Ducci,et al.  Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. , 2016, The New England journal of medicine.

[82]  C. Bruce,et al.  CT and MRI assessment of the aortic root and ascending aorta. , 2013, AJR. American journal of roentgenology.

[83]  Tim Beißbarth,et al.  Impact of frailty on short- and long-term morbidity and mortality after transcatheter aortic valve implantation: risk assessment by Katz Index of activities of daily living. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[84]  C. Vosa,et al.  Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. , 2009, Journal of the American College of Cardiology.

[85]  T. Sundt,et al.  Frequency of cardiovascular events in women with a congenitally bicuspid aortic valve in a single community and effect of pregnancy on events. , 2011, The American journal of cardiology.

[86]  M. Enriquez-Sarano,et al.  Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. , 1999, Circulation.

[87]  Jennifer G. Robinson,et al.  ACCF/AHA TASK FORCE MEMBERS , 2013 .

[88]  Jeroen J. Bax,et al.  Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis. , 2016, Journal of the American College of Cardiology.

[89]  A. Evangelista,et al.  Long-term outcome of surgically treated aortic regurgitation: influence of guideline adherence toward early surgery. , 2006, Journal of the American College of Cardiology.

[90]  Sean M. O'Brien,et al.  Influence of Hospital Procedural Volume on Care Process and Mortality for Patients Undergoing Elective Surgery for Mitral Regurgitation , 2007, Circulation.

[91]  J. Zamorano,et al.  Recommendations for the Imaging Assessment of Prosthetic Heart Valves , 2018 .

[92]  C. Tribouilloy,et al.  Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction: characteristics, outcome, and implications for surgery. , 2015, Journal of the American College of Cardiology.

[93]  R. Siegel,et al.  Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis. , 2009, The American journal of cardiology.

[94]  G. Breithardt,et al.  Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial , 2014, European heart journal.

[95]  P. Jüni,et al.  Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. , 2012, JACC. Cardiovascular interventions.

[96]  B. Gerber,et al.  Functional Anatomy of Aortic Regurgitation: Accuracy, Prediction of Surgical Repairability, and Outcome Implications of Transesophageal Echocardiography , 2007, Circulation.

[97]  C. Grines,et al.  Effect of Hospital Volume on Outcomes of Transcatheter Aortic Valve Implantation. , 2015, The American journal of cardiology.

[98]  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS The Task Force for the management of atrial fibrillation of the European Society of Cardiology ( ESC ) Developed with the special contribution of the Europ , 2016 .

[99]  J. Zamorano,et al.  European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[100]  Dimitris Mavridis,et al.  Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. , 2016, European heart journal.

[101]  P. Pibarot,et al.  Exercise testing and stress imaging in valvular heart disease. , 2014, The Canadian journal of cardiology.

[102]  R. de Caterina,et al.  Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial. , 2017, Journal of the American College of Cardiology.

[103]  M. Enriquez-Sarano,et al.  Echocardiographic Prediction of Survival After Surgical Correction of Organic Mitral Regurgitation , 1994, Circulation.

[104]  A. Speir,et al.  Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantation. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[105]  Andrew S. Mugglin,et al.  Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients , 2017, The New England journal of medicine.

[106]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[107]  G. Dreyfus,et al.  Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? , 2005, The Annals of thoracic surgery.

[108]  T. Sundt,et al.  Early thrombosis risk in patients with biologic valves in the aortic position. , 2012, The Journal of thoracic and cardiovascular surgery.

[109]  E. Prout.  Rheumatic heart disease. , 2020, Connecticut state medical journal.

[110]  L. Køber,et al.  Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and Bleeding , 2013 .

[111]  Susanna Price,et al.  2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). , 2014, European heart journal.

[112]  P. Pellikka,et al.  Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice. , 2014, European heart journal.

[113]  M. Enriquez-Sarano,et al.  Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. , 1997, Journal of the American College of Cardiology.

[114]  M. Enriquez-Sarano,et al.  Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. , 1999, Circulation.

[115]  D J Wheatley,et al.  Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses , 2003, Heart.

[116]  P. Pibarot,et al.  Paradoxical Low-Flow, Low-Gradient Severe Aortic Stenosis Despite Preserved Ejection Fraction Is Associated With Higher Afterload and Reduced Survival , 2007, Circulation.

[117]  B. Iung,et al.  Reinterventions after percutaneous mitral commissurotomy during long-term follow-up, up to 20 years: the role of repeat percutaneous mitral commissurotomy. , 2013, European heart journal.

[118]  Volkmar Falk,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca , 2014, European heart journal.

[119]  P. Pibarot,et al.  Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis , 2010, European heart journal.

[120]  Wen Cheng,et al.  Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study , 2017, The Lancet.

[121]  J. Zamorano,et al.  European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[122]  Jayant Nath,et al.  Impact of tricuspid regurgitation on long-term survival. , 2004, Journal of the American College of Cardiology.

[123]  C. Tribouilloy,et al.  Outcomes of pseudo-severe aortic stenosis under conservative treatment. , 2012, European heart journal.

[124]  B Cormier,et al.  Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. , 1996, Circulation.

[125]  Kristin L. Bussey-Smith,et al.  Evaluation of Warfarin Management with International Normalized Ratio Self‐Testing and Online Remote Monitoring and Management Plus Low‐Dose Vitamin K with Genomic Considerations: A Pilot Study , 2013, Pharmacotherapy.

[126]  P. Pibarot,et al.  Outcome of patients with aortic stenosis, small valve area, and low-flow, low-gradient despite preserved left ventricular ejection fraction. , 2012, Journal of the American College of Cardiology.

[127]  R. Guyton,et al.  Impact of preoperative chronic lung disease on survival after surgical aortic valve replacement. , 2013, The Annals of thoracic surgery.

[128]  G. Karthikeyan,et al.  Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies. , 2013, European heart journal.

[129]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[130]  J. Chambers,et al.  Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[131]  E. Schwammenthal,et al.  Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. , 2005, Circulation.

[132]  M. Enriquez-Sarano,et al.  Outcomes After Aortic Valve Replacement in Patients With Severe Aortic Regurgitation and Markedly Reduced Left Ventricular Function , 2002, Circulation.

[133]  Emilia Bagiella,et al.  Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. , 2016, The New England journal of medicine.

[134]  A. Berrebi,et al.  Management of multiple valve disease , 2010, Heart.

[135]  H. Rimington,et al.  Exercise testing to stratify risk in aortic stenosis. , 2005, European heart journal.

[136]  P. Oberti,et al.  Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. , 2009, Journal of the American College of Cardiology.

[137]  Sean M. O'Brien,et al.  Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement. , 2016, JAMA cardiology.

[138]  G. Siasos,et al.  Dual or Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation? A Systematic Review and Meta-Analysis. , 2016, Current pharmaceutical design.

[139]  S. Connolly,et al.  Dabigatran versus warfarin in patients with mechanical heart valves. , 2013, The New England journal of medicine.

[140]  R. Bonow,et al.  The emerging role of exercise testing and stress echocardiography in valvular heart disease. , 2009, Journal of the American College of Cardiology.

[141]  C. Tribouilloy,et al.  Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. , 2008, Journal of the American College of Cardiology.

[142]  H. Baumgartner,et al.  Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis , 2004, Circulation.

[143]  J. Mascherbauer,et al.  Right ventricular dysfunction, but not tricuspid regurgitation, is associated with outcome late after left heart valve procedure. , 2014, Journal of the American College of Cardiology.

[144]  J. Tabet,et al.  Low-Molecular-Weight Heparin as a Bridging Anticoagulant Early After Mechanical Heart Valve Replacement , 2006, Circulation.

[145]  B. Chang,et al.  Long-term clinical results of tricuspid valve replacement. , 2006, The Annals of thoracic surgery.

[146]  R. Whitlock,et al.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[147]  J. Zamorano,et al.  Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. , 2013, European heart journal cardiovascular Imaging.

[148]  G. Jondeau,et al.  Comparative assessment of ascending aortic aneurysms in Marfan patients using ECG-gated computerized tomographic angiography versus trans-thoracic echocardiography. , 2015, International Journal of Cardiology.

[149]  A. Camm,et al.  Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[150]  Jeroen J. Bax,et al.  Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair. , 2011, The Journal of thoracic and cardiovascular surgery.

[151]  S. Cha,et al.  Cardiac risk in patients aged >75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. , 2010, The American journal of cardiology.

[152]  P. Sorajja,et al.  Percutaneous repair of paravalvular prosthetic regurgitation: patient selection, techniques and outcomes , 2015, Heart.

[153]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[154]  Rosário Oliveira,et al.  Infective endocarditis in intravenous drug abusers: an update , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[155]  M. Schemper,et al.  Outcome of Watchful Waiting in Asymptomatic Severe Mitral Regurgitation , 2006, Circulation.

[156]  G. Maurer,et al.  The role of biomarkers in valvular heart disease: focus on natriuretic peptides. , 2014, The Canadian journal of cardiology.

[157]  T. Bental,et al.  Mid-term echocardiographic progression of patients with moderate aortic regurgitation: implications for aortic valve surgery. , 2013, Journal of Heart Valve Disease.

[158]  Jeevanantham Rajeswaran,et al.  Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. , 2007, Journal of the American College of Cardiology.

[159]  I. Palacios,et al.  Balloon mitral valvuloplasty in the United States: a 13-year perspective. , 2014, The American journal of medicine.

[160]  L. Shaw,et al.  Impact of early surgery on survival of patients with severe mitral regurgitation , 2010, Heart.

[161]  F. Tubach,et al.  Aortic Event Rate in the Marfan Population: A Cohort Study , 2012, Circulation.

[162]  L. Coombs,et al.  Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. , 2004, The Annals of thoracic surgery.

[163]  Maurice Buchbinder,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[164]  Francesco Maisano,et al.  Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease. , 2016, European heart journal.

[165]  A. Berrebi,et al.  Long-term results of external aortic ring annuloplasty for aortic valve repair. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[166]  D. Lachance,et al.  Usefulness of Carvedilol in the Treatment of Chronic Aortic Valve Regurgitation , 2011, Circulation. Heart failure.

[167]  Arturo Evangelista,et al.  European Association of Echocardiography recommendations for training, competence, and quality improvement in echocardiography. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[168]  J. Leipsic,et al.  Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. , 2016, European heart journal.

[169]  Seung‐Jung Park,et al.  Percutaneous Mitral Valvuloplasty Versus Surgical Treatment in Mitral Stenosis With Severe Tricuspid Regurgitation , 2007, Circulation.

[170]  Sean M. O'Brien,et al.  Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients. , 2015, The Annals of thoracic surgery.

[171]  M. Enriquez-Sarano,et al.  Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. , 2014, Journal of the American College of Cardiology.

[172]  Pascal Leprince,et al.  Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score , 2014, Heart.

[173]  M. Pasic,et al.  Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. , 2014, JAMA.

[174]  F. R. Rosendaal,et al.  Thromboembolic and Bleeding Complications in Patients With Mechanical Heart Valve Prostheses , 1994, Circulation.

[175]  Jean-Louis Vanoverschelde,et al.  EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[176]  J. Garot,et al.  Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes diagnostic accuracy and outcome implications. , 2005, Journal of the American College of Cardiology.

[177]  H. Schäfers,et al.  Aortic valve repair leads to a low incidence of valve-related complications. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[178]  R. di Bartolomeo,et al.  Does EuroSCORE II perform better than its original versions? A multicentre validation study. , 2013, European heart journal.

[179]  Robert J. Siegel,et al.  Percutaneous Repair or Surgery for Mitral Regurgitation , 2012 .

[180]  A. Zwinderman,et al.  Pregnancy and aortic root growth in the Marfan syndrome: a prospective study , 2005 .

[181]  Petr Ošťádal,et al.  Corrigendum to: 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. , 2017, European heart journal.

[182]  L. Pierard,et al.  Exercise Pulmonary Hypertension in Asymptomatic Degenerative Mitral Regurgitation , 2010, Circulation.

[183]  M. Schemper,et al.  Natural History of Very Severe Aortic Stenosis , 2010, Circulation.

[184]  P. Tornos,et al.  Enoxaparin as bridging anticoagulant treatment in cardiac surgery , 2007, Heart.

[185]  Michael J. Mack,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[186]  C. Rochitte,et al.  Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. , 2010, Journal of the American College of Cardiology.

[187]  G. El khoury,et al.  Valve-preserving surgery on the bicuspid aortic valve. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[188]  M. Borger,et al.  Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? , 2004, The Journal of thoracic and cardiovascular surgery.

[189]  Manesh R. Patel,et al.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. , 2010, Circulation.

[190]  D. Massel,et al.  Antiplatelet and anticoagulation for patients with prosthetic heart valves. , 2013, The Cochrane database of systematic reviews.

[191]  M. Mack,et al.  Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II. , 2015, Journal of the American College of Cardiology.

[192]  M. Enriquez-Sarano,et al.  Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction , 2010, Heart.

[193]  B. Prendergast,et al.  Specialist valve clinics: recommendations from the British Heart Valve Society working group on improving quality in the delivery of care for patients with heart valve disease , 2013, Heart.

[194]  M. Jahangiri,et al.  Myocardial deformation abnormalities in patients with aortic regurgitation: a strain rate imaging study. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[195]  S. Solomon,et al.  GUIDELINES AND STANDARDS , 2010 .

[196]  C. Bauters,et al.  Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation , 2010, Heart.

[197]  B. Iung,et al.  The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties. , 2014, European heart journal.

[198]  W G Henderson,et al.  Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. , 2000, Journal of the American College of Cardiology.